This year, 2018, marks the 40th anniversary of the FDA’s approval of cisplatin as an anti-cancer drug – an event not only of incredible significance in medicine, but to Michigan State University and the future of all research done on its campus.
Four decades later, cisplatin is making new discoveries possible every day. Below are stories that cover the discovery, inventors, patient survivors and researchers.
Discovering Cisplatin: The Penicillin of Cancer Drugs
Cancer-Fighting Innovators: The Rosenberg Lab
From Idea To Cure: Moving Ideas to Market at MSU
Today’s Cancer-Fighting Spartan Researchers
Long Term Impact of Innovation at MSU: a Virtuous Cycle
Success Stories: Patients Impacted by Cisplatin
The list of lives saved thanks to cisplatin is extensive. Here are profiles of patients who credit Cisplatin and Carboplatin along their healing journey.
Survivor Spotlight: Scott Hamilton
Survivor Spotlight: Deanna Pai
Survivor Spotlight: Jon Braeutigam
Survivor Spotlight: Patrick Garvey
Survivor Spotlight: Josh Wilson